subprojects are researching the introduction of the procedure into health care practice and are led by Professor Dr. Frank Lammert, Vice President of the Hannover Medical School (MHH) and one of the authors of [...] alcohol consumption. "Cirrhosis develops insidiously and often remains undetected at first," warns Professor Lammert. At the time of diagnosis, it is therefore often in an advanced stage and treatment options [...] person will develop cirrhosis and eventually develop liver cancer and die from the disease," says Professor Dr Michael Manns, MHH President and co-author of the study. "By calculating the risk early, preventive

from Hannover Medical School (MHH) led by Professor Dr. Britta Eiz-Vesper from the I nstitute of Transfusion Medicine and Transplant Engineering and Professor Dr. Britta Maecker-Kolhoff from the Department [...] recurrent EBV infection. "About 75 to 80 per cent of those affected responded to the treatment," says Professor Maecker-Kolhoff. "Overall, the cell therapy was very well tolerated." The results of the study have [...] patients "Thanks to our experience, we are able to produce the T cells within a few days," says Professor Eiz-Vesper. This is possible so quickly because the alloCELL register not only stores the HLA tissue

severe course of the disease in them," says Professor Cornberg. Hepatitis B can be treated well at an early stage, hepatitis C can even be cured. Professor Dr Michael P. Manns, MHH President and Chairman [...] stage "We have re-evaluated 165 recommendations and adapted them to the current situation," says Professor Dr Markus Cornberg, Deputy Director of the MHH Clinic for Gastroenterology, Hepatology and Endocrinology [...] not only in the 32nd week of pregnancy, as stipulated in the maternity guidelines," emphasises Professor Cornberg. "Early antiviral therapy can lower the mother's viral load and thus prevent chronic infection

faecal incontinence. Despite intensified relapse therapy, permanent impairments can occur," explains Professor Dr. Corinna Trebst, head of the study and vice director of the Department of Neurology. Large m [...] insufficient data on NMOSD and MOGAD in this regard. Dr. Hümmert coordinated the study together with Professor Trebst. 212 patients were included in the multicentre study - a very large number for a rare disease [...] study group, a network of more than 60 NMOSD centres in Germany, Austria and Switzerland," says Professor Trebst. MHH Neurology is one of the leading NEMOS centres. Through the network, the study initiators

SERVICE: For further information, please contact Professor Dr Günter Höglinger, hoeglinger.guenter@mh-hannover.de , telephone (0511) 532-2390, and Professor Dr Karin Weißenborn, weissenborn.karin@mh-hannover [...] permanent damage. The nationwide "Day against the Stroke" takes place on 10 May. On this occasion, Professor Dr Günter Höglinger reminds us how important it is to act immediately at the first sign of a stroke [...] the brain must be restored optimally within a maximum of 4.5 hours after the stroke," explains Professor Dr Karin Weißenborn, head of the certified supraregional stroke unit at the MHH Department of Neurology

virus-infested cells and tumor cells. This makes NK cells interesting helpers in cancer therapy. Professor Dr. Dr. Axel Schambach, head of the Institute of Experimental Haematology at the Hannover Medical [...] ensure greater targeting accuracy and more extensive destruction of the tumor cells,” explains Professor Schambach. In order to activate the NK cells, they receive an additional genetic code for the chimeric [...] structures that are mainly located on the tumor cell, but not on the patient’s immune cells,” says Professor Schambach. Soften immunosuppression in tumor environment However, the CAR-NK cells have a further

multi-centre study with 150 participants, an international research team led by Professor Dr. Heiner Wedemeyer and Professor Dr. Markus Cornberg from the Department of Gastroenterology, Hepatology, Infectiology [...] show how long the patients will have to be treated in the end. The researchers led by Professor Wedemeyer and Professor Cornberg are also investigating this in the EU-funded research project D-Solve. What [...] "We tested the antiviral activity on 150 patients who were infected with both HBV and HDV," says Professor Cornberg. "Of these, just under half had already developed liver cirrhosis, i.e. scarred liver tissue

when the body's own defence reaction goes into overdrive and attacks its own organs," explains Professor Dr. Sascha David from the Clinic for Kidney and Hypertension Diseases at the MHH and the Institute [...] supported with dialysis. "It is important to diagnose sepsis early and start therapy immediately," says Professor David. Without medical care, the risk of death increases by seven per cent per hour. Healthy plasma [...] exchange is not a new procedure. However, it is not yet established in the treatment of septic shock. Professor David's "Translational Intensive Care Medicine" working group, which also includes private lecturer

pies in order to better adapt the treatment to the individual needs of the patients," explains Professor Dr. Kai Kahl, head of the MHH study centre. The ChangePDD project is funded by the German Research [...] suffering cardiovascular diseases, slipping into incapacity to work and early retirement," says Professor Kahl. This is not only an extremely difficult situation for those affected personally, but also [...] Philippa Gebhardt is coordinating the study, six other study centres are involved in the project. Professor Dr Eva-Lotta Brakemeier from the University of Greifswald is in charge of the study. Established

inflammatory diseases, allergies, obesity and diabetes in the long term. A team led by scientist Professor Dr Dorothee Viemann, Hannover Medical School (MHH) and Cluster of Excellence RESIST as well as [...] Research (BMBF) is supporting this project with around 1.9 million euros. Alarmins could be the key Professor Viemann and PD Dr. Sabine Pirr had previously discovered that so-called alarmins positively influence [...] "The risk of sepsis increases significantly if premature babies lack alarmin S100A8/A9," says Professor Viemann. The PROSPER project (Prevention of Sepsis by personalised nutritional S100A8/A9 supplementation